Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025)

Invivyd (IVVD) reported Other Accumulated Expenses of $52000.0 for Q4 2025, up 92.59% on a YoY basis from $27000.0 in Q4 2024, and up 62.5% quarter-over-quarter from $32000.0 in Q3 2025.

Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Invivyd has reported Other Accumulated Expenses for 4 years, with the latest figure at $52000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 92.59% year-over-year to $52000.0; the trailing twelve-month figure through Dec 2025 stood at $52000.0 (up 92.59% YoY), and the FY2025 full-year result was $52000.0, up 92.59% from the prior year.
  • Other Accumulated Expenses for Q4 2025 stood at $52000.0, up from $32000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $58000.0 in Q2 2022, with the low at $20000.0 in Q3 2024.
  • Historically, Other Accumulated Expenses has averaged $37666.7 across 4 years, with a median of $35000.0 in 2023.
  • Annual changes were most pronounced in 2023 — Other Accumulated Expenses slumped 49.06% — and 2025, when it surged 92.59%.
  • Invivyd's Other Accumulated Expenses stood at $44000.0 in 2022, then fell by 20.45% to $35000.0 in 2023, then slipped by 22.86% to $27000.0 in 2024, then surged by 92.59% to $52000.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $52000.0 (Q4 2025), $32000.0 (Q3 2025), and $26000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Invivyd 168.41 Mn -58.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 52,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 34,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 27,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 44,000.00
Sep 30, 2022 53,000.00
Jun 30, 2022 58,000.00